Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Besides the q-figures the future prospects are important......

Yes, that $-szenario is a little problem.........

I am not sure, if the steady income is just the only reason that institutional investors don't buy PTSC. Besides that, the uncertanity of the reex. and the missing transparancy are still some other topics.

S402005

Share
New Message
Please login to post a reply